AHPA St. John's Wort, Saw Palmetto Labeling Guidances Issued
This article was originally published in The Tan Sheet
Executive Summary
Guidances recommending cautionary statements on the labeling of St. John's wort and saw palmetto products were adopted recently by the American Herbal Products Association's Board of Trustees.
You may also be interested in...
St. John's Wort, Rx Drug Use Warning Adopted By CHPA
Consumer Healthcare Products Association member companies soon will be incorporating a prescription drug use warning on their St. John's wort supplements.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands